Photobiomodulation and Class 3B Laser Therapy for Pets: WALT Protocols Explained

What Photobiomodulation Is

Photobiomodulation — abbreviated PBM, and formerly called low-level laser therapy or LLLT — is the use of red and near-infrared light wavelengths to deliver therapeutic effects in biological tissue. The term “photobiomodulation” replaced “low-level laser therapy” in the scientific literature because the latter conflated dose with mechanism; PBM is now the preferred term in journals, conference proceedings, and credentialing bodies.

In a veterinary rehabilitation context, PBM is most commonly delivered by Class 3B laser devices. The technology is widespread, the safety profile when used correctly is excellent, and the evidence base — strongest for wound healing and emerging-to-strong for selected pain and inflammatory indications — has grown substantially over the past 15 years. This article explains how PBM works at the cellular level, what the Class 3B classification means, what WALT-protocol guidance recommends, and how to evaluate a clinic’s laser offering.

Evidence Tier

Evidence tier: STRONG for wound healing and post-surgical tissue support; EMERGING-to-STRONG for osteoarthritis pain and soft-tissue inflammation; MIXED for some other claimed indications. Wound-healing evidence is the most robust — multiple controlled studies and clinical practice patterns support PBM as an adjunct to incision care, dehiscence-prone wound management, and chronic skin lesions. Pain-management evidence for canine OA is growing and is included in multimodal-care recommendations. Sports-medicine and tendinopathy applications continue to accumulate evidence. PBM is not magic; it is one tool in a multimodal toolkit.

The World Association for Laser Therapy (WALT) maintains dose recommendations that have evolved over multiple consensus revisions. Credible veterinary laser practice uses WALT-informed dosing rather than improvising joules-per-square-centimeter values from the device’s pre-set buttons.

The Cellular Mechanism

The leading mechanistic model for PBM centers on cytochrome c oxidase, a key enzyme in the mitochondrial electron transport chain. Red and near-infrared photons in specific wavelength ranges (roughly 600–1000 nanometers) are absorbed by cytochrome c oxidase, transiently displacing nitric oxide and increasing electron transport efficiency. The downstream effects include modestly increased ATP production, transient changes in reactive oxygen species, modulation of intracellular signaling, and — at the tissue level — anti-inflammatory effects, accelerated wound healing, and analgesia in selected indications.

This is the part of PBM that has the firmest scientific footing. The mechanism is plausible, replicable in cell culture, and consistent with the clinical outcomes seen in controlled studies. The mechanism does not, by itself, validate every clinical claim made for laser therapy — wavelength, dose, treatment site, and indication all matter — but it does establish that PBM is biologically real, not placebo.

What Class 3B Means

The “Class 3B” designation comes from FDA and international laser-safety classifications based on power output. Class 3B lasers deliver between 5 milliwatts and 500 milliwatts of optical power. They are the workhorse of outpatient veterinary rehab — powerful enough to deliver meaningful therapeutic doses in reasonable session times, but below the thermal-injury threshold of Class 4 (>500 mW) devices.

Class 3B safety profile is excellent in trained hands. Eye protection (proper laser-safety goggles for both clinician and patient when feasible) is mandatory because direct beam exposure to the retina can cause injury. Skin thermal injury at correct doses is essentially nonexistent at Class 3B power levels. The classification distinguishes 3B from higher-output Class 4 lasers, which deliver greater tissue penetration but require more careful handling to avoid thermal injury.

WALT Protocols and Why They Matter

The World Association for Laser Therapy publishes dose recommendation tables for various indications and tissue types. The recommendations specify a target energy density (joules per square centimeter) at the target tissue, a wavelength range, and treatment-frequency guidance. WALT has periodically revised these tables as evidence has accumulated.

A clinically credible veterinary laser practice uses WALT-informed dosing — calculating the appropriate joules per square centimeter for the target tissue, factoring in body-surface absorption and depth, and adjusting treatment time accordingly. A practice that simply pushes a pre-set button on the device without understanding the underlying dose math is using laser therapy in a way that can underdeliver (too little dose = no effect) or, less commonly, overdeliver (excessive dose may actually impair healing — the so-called biphasic dose response).

Wavelengths in Clinical Use

Veterinary PBM devices typically deliver one or more wavelengths in the red-to-near-infrared range. Common clinical wavelengths include 635 nm and 660 nm (red), 808 nm (near-infrared), 830 nm, 904 nm (pulsed), and 980 nm. Different wavelengths penetrate to different tissue depths and have somewhat different absorption profiles.

Red wavelengths (around 600–700 nm) are absorbed more superficially and are favored for skin lesions and shallow tissue. Near-infrared wavelengths (around 800–1000 nm) penetrate deeper and are favored for joint, muscle, and deeper soft-tissue work. Multi-wavelength devices that combine red and near-infrared in one treatment head are increasingly common and let the clinician address both superficial and deeper tissue in a single session.

Indications Where PBM Has the Best Evidence

Wound healing is the strongest PBM indication. Post-surgical incision support, dehiscence-prone wound management, chronic non-healing wounds, and selected skin lesions all respond to appropriately dosed PBM. Surgical drain site management and post-amputation incision support are common rehab applications.

Osteoarthritis pain is the second major indication. PBM is part of the multimodal-OA toolkit alongside weight management, NSAIDs, joint-disease-modifying agents, rehab exercise, and selected supplements. The 2022 AAHA Pain Management Guidelines recognize PBM as a component of multimodal canine OA care. See our piece on canine OA for the broader pain-management framework.

Soft-tissue and tendon inflammation — sports-medicine indications, supraspinatus tendinopathy, and selected muscle-strain cases — represent the third indication cluster. Post-operative pain and inflammation support fall under both the wound-healing and pain-management umbrellas. PBM is also used adjunctively in some dermatologic cases — pyotraumatic dermatitis, interdigital lesions, perianal lesions — where superficial-tissue laser dosing applies.

How PBM Compares to Other Rehab Modalities

Within a multimodal rehab plan, PBM occupies a distinct niche. It is non-invasive, requires no sedation, can be combined with virtually every other modality in the same session, and has an excellent safety profile when used correctly. Compared to therapeutic ultrasound, PBM has stronger published evidence for several common indications. Compared to extracorporeal shockwave therapy, PBM has a broader indication range but less penetration depth and less mechanical-stimulation effect.

PBM is not a replacement for therapeutic exercise, hydrotherapy, or appropriate pharmacologic pain control. It is a complementary modality that improves tissue-level conditions and reduces pain at the treated sites. The strongest rehab outcomes typically come from coordinated multimodal plans, not from any single modality used in isolation.

The Class 3B versus Class 4 Question

A frequent question is whether higher-power Class 4 lasers are simply better. The honest answer is more nuanced: Class 4 delivers greater tissue penetration and shorter treatment times per session but requires more careful technique to avoid thermal injury. Class 3B delivers similar therapeutic doses in slightly longer sessions with a wider thermal-safety margin. For many common indications, both classes deliver acceptable outcomes. The practical question is not “which class” but “which dose, wavelength, and protocol for which indication.” Our deep dive on cold laser vs Class 4 laser therapy walks through the comparison in detail.

Safety, Eye Protection, and Contraindications

Eye protection is the most important safety requirement. Both clinician and patient should be protected from direct beam exposure to the eye; appropriate laser-safety goggles (wavelength-rated for the device in use) are standard. Patient cooperation matters — a fearful, fidgeting patient is harder to protect than a calm one, which is one reason rehab teams invest in cooperative-care and low-stress handling.

Common contraindications include direct application over malignancy (avoid lasing known tumor sites), over the gravid uterus, over open growth plates in young animals (caution; consult device guidance), over photosensitizing skin conditions, and on hyperthermic patients. Tattoos, dark pigmentation, and dense hair coats absorb more light energy and may require dose adjustment. A credentialed rehab clinician screens for contraindications and selects parameters accordingly.

What to Look For in a Laser Practice

Several signals distinguish a clinically credible laser practice from a practice that bought the device and pushes the preset buttons. The clinician calculates and records joules per square centimeter for each treatment site. WALT-informed dose targets are explicitly referenced. Wavelength selection is matched to indication and tissue depth. Eye protection is used routinely. The laser is part of a written, multimodal rehab plan with measurable goals, not a standalone “shine the light, send the bill” offering.

Ask the clinic: which device do you use; what wavelengths does it deliver; how do you calculate dose; do you reference WALT or other published dose protocols; is laser therapy delivered by a credentialed rehab clinician or by a technician under the clinician’s prescription? A confident, specific response signals competence. Vague answers signal a marketing-driven implementation.

Frequently Asked Questions

Is laser therapy the same as photobiomodulation?

Photobiomodulation (PBM) is the modern scientific term that replaced “low-level laser therapy” (LLLT). Class 3B and Class 4 laser devices are the most common delivery modalities for veterinary PBM. The mechanism — wavelength-specific photon absorption at the cellular level — is the same regardless of the marketing term.

How many sessions will my pet need?

Highly indication-dependent. Wound healing may need 2–3 times per week for several weeks. Chronic OA maintenance is often once or twice weekly initially with taper to maintenance. Acute soft-tissue injury may use a shorter, more intensive course. Your rehab clinician will personalize the protocol.

Does laser therapy hurt?

No — PBM at Class 3B doses is painless. The treatment head is applied to the skin or held just above it; the patient typically feels mild warmth or nothing at all. Many pets relax during sessions.

Is laser therapy safe for cancer patients?

Direct application over a known tumor site is contraindicated. Laser therapy at non-tumor sites in cancer patients is generally fine and is sometimes used for adjunct pain management — coordinate with the oncology team. Discuss the specific case with your oncologist and rehab clinician.

Can I buy a home laser device for my pet?

Home consumer laser devices are widely sold; quality and accurate dose delivery vary widely. Most rehab clinicians caution against home use without veterinary guidance — the wrong wavelength, dose, or treatment-site selection can underdeliver therapeutic effect or, less commonly, impair healing. If you are considering home laser, discuss with your rehab team first.